Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G2A | P14555 | 5/20 | 0.44 |
| ▸ | PLA2G4A | P47712 | 5/20 | 0.44 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.40 |
| ▸ | PRKDC | P78527 | 3/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.37 |
| ▸ | MAPT | P10636 | 3/20 | 0.37 |
| ▸ | HPGD | P15428 | 3/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | NPC1 | O15118 | 2/20 | 0.37 |
| ▸ | RAB9A | P51151 | 2/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | PGR | P06401 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 2/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.35 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.35 |
| ▸ | CASP3 | P42574 | 1/20 | 0.35 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25633921 | 1.00 | PLA2G2A (0.44) | PLA2G2APLA2G4APLA2G10PRKDCKDM4E | |
| SCHEMBL24505849 | 0.97 | PLA2G2A (0.44) | PLA2G2APLA2G4APLA2G10PRKDCKDM4E | |
| SCHEMBL27115148 | 0.94 | PLA2G2A (0.41) | PLA2G2APLA2G4APLA2G10PRKDCKDM4E | |
| SCHEMBL23849062 | 0.94 | PLA2G2A (0.41) | PLA2G2APLA2G4APLA2G10PRKDCKDM4E | |
| SCHEMBL24926036 | 0.94 | PLA2G2A (0.44) | PLA2G2APLA2G4APLA2G10PRKDCKDM4E | |
| SCHEMBL22130578 | 0.92 | MAPT (0.40) | PLA2G2APLA2G4APLA2G10KDM4EMAPT | |
| SCHEMBL24247328 | 0.91 | MAPT (0.44) | PLA2G2APLA2G4APLA2G10KDM4EMAPT | |
| SCHEMBL24177852 | 0.91 | MAPT (0.46) | PLA2G2APLA2G4APLA2G10KDM4EMAPT | |
| SCHEMBL24064859 | 0.90 | NPC1 (0.42) | PLA2G2APLA2G4APLA2G10PRKDCKDM4E | |
| SCHEMBL27113014 | 0.89 | PLA2G2A (0.41) | PLA2G2APLA2G4APLA2G10PRKDCKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230371376-A1 | POLYCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING SAME | SFC CO., LTD. (KR) | 2023-11-16 | — | — | US | disclosed |
| US-10693084-B2 | Compound for organic light-emitting device and organic light-emitting device including same | SFC CO., LTD. (KR) | 2020-06-23 | — | — | US | disclosed |
| US-20180123055-A1 | COMPOUND FOR ORGANIC LIGHT-EMITTING DEVICE AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING SAME | SFC CO., LTD. (KR) | 2018-05-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10693084-B2 | Compound for organic light-emitting device and organic light-emitting device including same | CYP1B1, CYP1A1, CRY2 | PLA2G2A 1057/4885PLA2G4A 1308/4885PLA2G10 1475/4885 |
| US-20230371376-A1 | POLYCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING SAME | PPOX, MAP1LC3A, VDAC2 | PLA2G2A 1893/4885PLA2G4A 1054/4885PLA2G10 857/4885 |
| US-20180123055-A1 | COMPOUND FOR ORGANIC LIGHT-EMITTING DEVICE AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING SAME | CYP1B1, CYP1A1, CRY2 | PLA2G2A 1057/4885PLA2G4A 1308/4885PLA2G10 1475/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.